Rob DillardHeart Failure | February 12, 2024
Many cardio-oncology patients at increased risk for congestive heart failure from cancer therapy have OSA.
Read More
Rob DillardBreast Cancer | February 12, 2024
Completing HBOT appears effective at reducing pain and fibrosis in patients with irradiated breast cancer.
Pavlos Msaouel, MD, PhDOncology | February 12, 2024
What does the data and overall understanding of VEGF-TKIs tell us about which patients are optimal candidates for tivozanib?
The Fellow on CallThe Fellow on Call | February 1, 2024
Dr. Jacob Hall joins The Fellow on Call group to discuss patient selection for radiation therapy for prostate cancer.
Rob DillardBreast Cancer | February 1, 2024
A researcher is looking to prove that nebivolol, an FDA-approved drug for high blood pressure, is effective at treating TNBC.
Chadi Nabhan, MD, MBAHealthcare Unfiltered | February 2, 2024
Dr. Salma Jabbour joins Dr. Chadi Nabhan to provide her invaluable perspective on the PROSPECT trial findings.
The Fellow on CallThe Fellow on Call | January 29, 2024
Dr. Sanjay Patel joins The Fellow on Call team to discuss prostate cancer from the perspective of a urologist.
Rob DillardCervical Cancer | January 25, 2024
LSU LCMC Health Cancer Center has been awarded a $1.5 million grant to help combat barriers to cervical cancer prevention.
Rob DillardBreast Cancer | January 22, 2024
Screening and new treatments have led to a US breast cancer mortality rate that is 58% lower than in it was in the mid-1970s.
Ashley GainesBreast Cancer | January 18, 2024
The FDA recently approved a new combination therapy for the treatment of HR-positive, HER2-negative breast cancer.
Rob DillardSkin Cancer | January 18, 2024
DermaSensor announced this week that the US FDA cleared its AI-based handheld device for detecting skin cancer.
Rob DillardHeart Failure | January 11, 2024
City of Hope and COG conducted a clinical trial with the goal of reducing HF risk in childhood cancer survivors.
Rob DillardGynecologic Cancer | January 10, 2024
According to a retrospective study, a high preoperative CONUT score indicates poor prognosis in cervical cancer.
Rob DillardBreast Cancer | January 9, 2024
CNS radiotherapy with pyrotinib and capecitabine improves CNS progression in breast cancer patients with brain metastases.
Oncology BrothersOncology Brothers | December 21, 2023
The Oncology Brothers talk with Paolo Tarantino, MD, about the TROPiCS-02 study presented at SABCS.
The Fellow on CallThe Fellow on Call | December 19, 2023
The Fellow on Call team provides a nuanced overview of the individual chemotherapy agents used in the clinical setting.
Chadi Nabhan, MD, MBAHealthcare Unfiltered | December 19, 2023
Dr. Chadi Nabhan and experts discuss the intricate relationship between the microbiome and cancer.
Rob DillardConference Coverage | December 14, 2023
A noninvasive magnetic resonance imaging technique can effectively evaluate bone marrow in patients with myelofibrosis.
Rob DillardConference Coverage | December 14, 2023
CALR-1 mutation is an important risk factor for both drug survival and longevity in momelotinib-treated patients with MF.
Latest News

February 23, 2024